Al's Comment:

 Still very early to say how effective it is but this is a new option for DIPG and DMG with H3K27m mutation.  They identified a new type of side effect but also were able to treat it.  They say one of the patients had a > 90% reduction in tumor size!


Posted on: 04/20/2021

Novel CAR-T shows 'promising early signs of clinical efficacy' for diffuse midline gliomas


Click HERE to return to brain tumor news headlines.